{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T20:38:16Z","timestamp":1790800696456,"version":"4.1.0"},"reference-count":37,"publisher":"Oxford University Press (OUP)","issue":"2","funder":[{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Cambridge Biomedical Research Centre"},{"DOI":"10.13039\/100006432","name":"Terumo BCT","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006432","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The outcomes in patients with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis have improved significantly over the past decades, although a significant proportion of them still reach end-stage renal disease (ESRD). Renal replacement therapy (RRT) is associated with a relatively low risk of relapsing vasculitis as a result of anti-rejection treatment after kidney transplantation or quiescence of the autoimmune process in haemodialysis patients, but a flare of vasculitis in the latter setting presents a challenge because the treatment is poorly tolerated. There are benefits of rituximab in haemodialysed patients, as it is more steroid sparing in the treatment of extrarenal disease. More favourable outcomes of kidney transplantation compared with haemodialysis support its use as a preferable method of RRT in patients with vasculitis remission or low disease activity.<\/jats:p>","DOI":"10.1093\/ndt\/gfw046","type":"journal-article","created":{"date-parts":[[2016,4,8]],"date-time":"2016-04-08T14:27:20Z","timestamp":1460125640000},"page":"248-253","source":"Crossref","is-referenced-by-count":59,"title":["End-stage renal disease in ANCA-associated vasculitis"],"prefix":"10.1093","volume":"32","author":[{"given":"Sergey","family":"Moiseev","sequence":"first","affiliation":[{"name":"1Clinic of Nephrology, Internal and Occupational Diseases, Sechenov First Moscow State Medical University, Moscow, Russian Federation"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavel","family":"Novikov","sequence":"additional","affiliation":[{"name":"1Clinic of Nephrology, Internal and Occupational Diseases, Sechenov First Moscow State Medical University, Moscow, Russian Federation"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Jayne","sequence":"additional","affiliation":[{"name":"2Vasculitis and Lupus Clinic, Addenbrooke's Hospital, Cambridge, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolay","family":"Mukhin","sequence":"additional","affiliation":[{"name":"1Clinic of Nephrology, Internal and Occupational Diseases, Sechenov First Moscow State Medical University, Moscow, Russian Federation"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2016,4,6]]},"reference":[{"key":"2025102312491597800_gfw046C1","doi-asserted-by":"crossref","first-page":"36","DOI":"10.5499\/wjr.v5.i1.36","article-title":"Classification, diagnosis and treatment of ANCA-associated vasculitis","volume":"5","author":"Moiseev","year":"2015","journal-title":"World J Rheumatol"},{"key":"2025102312491597800_gfw046C2","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1136\/annrheumdis-2013-203927","article-title":"Damage in the ANCA-associated vasculitides: long-term data from the European Vasculitis Study group (EUVAS) therapeutic trials","volume":"74","author":"Robson","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"2025102312491597800_gfw046C3","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.3899\/jrheum.131038","article-title":"Population-based study showing better renal prognosis for proteinase 3 antineutrophil cytoplasmic antibody (ANCA)-associated nephritis versus myeloperoxidase ANCA-associated nephritis","volume":"41","author":"Mohammad","year":"2014","journal-title":"J Rheumatol"},{"key":"2025102312491597800_gfw046C4","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/ki.2009.218","article-title":"The clinical course of ANCA small-vessel vasculitis on chronic dialysis","volume":"76","author":"Lionaki","year":"2009","journal-title":"Kidney Int"},{"key":"2025102312491597800_gfw046C5","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/S0272-6386(03)00025-8","article-title":"Outcome of ANCA-associated renal vasculitis: a 5-year retrospective study","volume":"41","author":"Booth","year":"2003","journal-title":"Am J Kidney Dis"},{"issue":"(2 Suppl 89)","key":"2025102312491597800_gfw046C6","first-page":"S77","article-title":"Comparability of patients with ANCA-associated vasculitis enrolled in clinical trials or in observational cohorts","volume":"33","author":"Pagnoux","year":"2015","journal-title":"Clin Exp Rheumatol"},{"key":"2025102312491597800_gfw046C7","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1136\/annrheumdis-2012-201750","article-title":"Revisiting the classification of clinical phenotypes of anti-neutrophil cytoplasmic antibody-associated vasculitis: a cluster analysis","volume":"72","author":"Mahr","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"2025102312491597800_gfw046C8","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1056\/NEJMoa1108735","article-title":"Genetically distinct subsets within ANCA-associated vasculitis","volume":"367","author":"Lyons","year":"2012","journal-title":"N Engl J Med"},{"key":"2025102312491597800_gfw046C9","doi-asserted-by":"crossref","first-page":"3452","DOI":"10.1002\/art.34562","article-title":"Classification of antineutrophil cytoplasmic autoantibody vasculitides: the role of antineutrophil cytoplasmic autoantibody specificity for myeloperoxidase or proteinase 3 in disease recognition and prognosis","volume":"64","author":"Lionaki","year":"2012","journal-title":"Arthritis Rheum"},{"key":"2025102312491597800_gfw046C10","doi-asserted-by":"crossref","first-page":"621","DOI":"10.7326\/0003-4819-143-9-200511010-00005","article-title":"Predictors of relapse and treatment resistance in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis","volume":"143","author":"Hogan","year":"2005","journal-title":"Ann Intern Med"},{"key":"2025102312491597800_gfw046C11","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1681\/ASN.2010050477","article-title":"Histopathologic classification of ANCA-associated glomerulonephritis","volume":"21","author":"Berden","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"2025102312491597800_gfw046C12","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/1471-2369-14-125","article-title":"Validation of a newly proposed histopathological classification in Japanese patients with anti-neutrophil cytoplasmic antibody-associated glomerulonephritis","volume":"14","author":"Iwakiri","year":"2013","journal-title":"BMC Nephrol"},{"key":"2025102312491597800_gfw046C13","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1093\/ndt\/gfr643","article-title":"Re-evaluation of the histopathologic classification of ANCA-associated glomerulonephritis: a study of 121 patients in a single center","volume":"27","author":"Chang","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"2025102312491597800_gfw046C14","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/j.humpath.2014.02.017","article-title":"Validation of a histopathologic classification scheme for antineutrophil cytoplasmic antibody-associated glomerulonephritis","volume":"45","author":"Nohr","year":"2014","journal-title":"Hum Pathol"},{"key":"2025102312491597800_gfw046C15","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1053\/j.ajkd.2013.08.025","article-title":"Histopathologic and clinical predictors of kidney outcomes in ANCA-associated vasculitis","volume":"63","author":"Ford","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"2025102312491597800_gfw046C16","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1093\/ndt\/gfu237","article-title":"Long-term outcome of anti-neutrophil cytoplasm antibody-associated glomerulonephritis: evaluation of the international histological classification and other prognostic factors","volume":"30","author":"Tanna","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"2025102312491597800_gfw046C17","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa0909169","article-title":"Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis","volume":"363","author":"Jones","year":"2010","journal-title":"N Engl J Med"},{"key":"2025102312491597800_gfw046C18","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJMoa1213277","article-title":"Efficacy of remission-induction regimens for ANCA-associated vasculitis","volume":"369","author":"Specks","year":"2013","journal-title":"N Engl J Med"},{"key":"2025102312491597800_gfw046C19","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1681\/ASN.2014010046","article-title":"Rituximab versus cyclophosphamide for ANCA-associated vasculitis with renal involvement","volume":"26","author":"Geetha","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"2025102312491597800_gfw046C20","article-title":"Rituximab for treatment of severe renal disease in ANCA associated vasculitis","author":"Geetha","year":"2015","journal-title":"J Nephrol"},{"key":"2025102312491597800_gfw046C21","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1159\/000431336","article-title":"Treatment of severe renal disease in ANCA positive and negative small vessel vasculitis with rituximab","volume":"41","author":"Shah","year":"2015","journal-title":"Am J Nephrol"},{"key":"2025102312491597800_gfw046C22","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1056\/NEJMoa020286","article-title":"A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies","volume":"349","author":"Jayne","year":"2003","journal-title":"N Engl J Med"},{"key":"2025102312491597800_gfw046C23","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1001\/jama.2010.1658","article-title":"Mycophenolate mofetil vs azathioprine for remission maintenance in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized controlled trial","volume":"304","author":"Hiemstra","year":"2010","journal-title":"JAMA"},{"key":"2025102312491597800_gfw046C24","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1056\/NEJMoa1404231","article-title":"Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis","volume":"371","author":"Guillevin","year":"2014","journal-title":"N Engl J Med"},{"key":"2025102312491597800_gfw046C25","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1681\/ASN.2007010090","article-title":"Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis","volume":"18","author":"Jayne","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"2025102312491597800_gfw046C26","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/ki.2013.131","article-title":"Long-term follow-up of patients with severe ANCA-associated vasculitis comparing plasma exchange to intravenous methylprednisolone treatment is unclear","volume":"84","author":"Walsh","year":"2013","journal-title":"Kidney Int"},{"issue":"(1 Suppl 70)","key":"2025102312491597800_gfw046C27","first-page":"S39","article-title":"Early plasma exchange improves outcome in PR3-ANCA-positive renal vasculitis","volume":"30","author":"Gregersen","year":"2012","journal-title":"Clin Exp Rheumatol"},{"key":"2025102312491597800_gfw046C28","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/BOR.0b013e32834120c1","article-title":"Plasma exchange in the treatment of Wegener's granulomatosis, microscopic polyangiitis, Churg-Strauss syndrome and renal limited vasculitis","volume":"23","author":"Casian","year":"2011","journal-title":"Curr Opin Rheumatol"},{"key":"2025102312491597800_gfw046C29","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/1745-6215-14-73","article-title":"Plasma exchange and glucocorticoid dosing in the treatment of anti-neutrophil cytoplasm antibody associated vasculitis (PEXIVAS): protocol for a randomized controlled trial","volume":"14","author":"Walsh","year":"2013","journal-title":"Trials"},{"key":"2025102312491597800_gfw046C30","first-page":"293","article-title":"End-stage renal failure in systemic lupus erythematosus with nephritis","volume":"22","author":"Correia","year":"1984","journal-title":"Clin Nephrol"},{"key":"2025102312491597800_gfw046C31","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1053\/j.ajkd.2007.04.018","article-title":"Recurrences and infections during continuous immunosuppressive therapy after beginning dialysis in ANCA-associated vasculitis","volume":"50","author":"Weidanz","year":"2007","journal-title":"Am J Kidney Dis"},{"key":"2025102312491597800_gfw046C32","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1681\/ASN.V971258","article-title":"Outcome of renal replacement therapy in antineutrophil cytoplasmic antibody-associated systemic vasculitis","volume":"9","author":"Allen","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"2025102312491597800_gfw046C33","first-page":"139","article-title":"KDIGO Clinical Practice Guideline for Glomerulonephritis","volume":"2","author":"Kidney Disease: Improving Global Outcomes (KDIGO) Glomerulonephritis Work Group","year":"2012","journal-title":"Kidney Int Suppl"},{"key":"2025102312491597800_gfw046C34","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1053\/j.ajkd.2015.03.025","article-title":"Characteristics and outcomes of granulomatosis with polyangiitis (Wegener) and microscopic polyangiitis requiring renal replacement therapy: results from the European Renal Association\u2013European Dialysis and Transplant Association Registry","volume":"66","author":"Hruskova","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"2025102312491597800_gfw046C35","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1093\/qjmed\/hcu043","article-title":"Survival of patients with ANCA-associated vasculitis on chronic dialysis: data from the French REIN registry from 2002 to 2011","volume":"107","author":"Romeu","year":"2014","journal-title":"QJM"},{"key":"2025102312491597800_gfw046C36","doi-asserted-by":"crossref","first-page":"773","DOI":"10.2215\/CJN.08770812","article-title":"The outcomes of patients with ESRD and ANCA-associated vasculitis in Australia and New Zealand","volume":"8","author":"Tang","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"2025102312491597800_gfw046C37","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1093\/ndt\/gfp347","article-title":"Renal transplantation in systemic vasculitis: when is it safe?","volume":"24","author":"Little","year":"2009","journal-title":"Nephrol Dial Transplant"}],"container-title":["Nephrology Dialysis Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ndt\/article-pdf\/32\/2\/248\/17822637\/gfw046.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ndt\/article-pdf\/32\/2\/248\/17822637\/gfw046.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T16:50:00Z","timestamp":1761238200000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ndt\/article\/32\/2\/248\/2982343"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,6]]},"references-count":37,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2016,4,6]]},"published-print":{"date-parts":[[2017,2,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ndt\/gfw046","relation":{},"ISSN":["0931-0509","1460-2385"],"issn-type":[{"value":"0931-0509","type":"print"},{"value":"1460-2385","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,2]]},"published":{"date-parts":[[2016,4,6]]}}}